Cadrenal Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CVKD and other ETFs, options, and stocks.

About CVKD

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focused on developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. 

CEO
Quang X. Pham
CEOQuang X. Pham
Employees
4
Employees4
Headquarters
Ponte Vedra Beach, Florida
HeadquartersPonte Vedra Beach, Florida
Founded
2022
Founded2022
Employees
4
Employees4

CVKD Key Statistics

Market cap
11.91M
Market cap11.91M
Price-Earnings ratio
-1.84
Price-Earnings ratio-1.84
Dividend yield
—
Dividend yield—
Average volume
43.73K
Average volume43.73K
High today
$11.59
High today$11.59
Low today
$11.00
Low today$11.00
Open price
$11.06
Open price$11.06
Volume
37.08K
Volume37.08K
52 Week high
$32.55
52 Week high$32.55
52 Week low
$5.40
52 Week low$5.40
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.